This study of patients with breast cancer, ovarian cancer, or both compared with controls uses whole-exome sequencing to investigate whether non-BRCA genes are associated with an increased risk of those cancers.
Richard SchilskyAssociation of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing
The ASCO Health Policy Leadership Development Program – formerly named the Health Policy Fellowship – is a formal professional development program designed to build policy and leadership expertise among the Society’s members and volunteers.
Richard SchilskyTime to apply is short. Don’t miss the opportunity to transform your career! The ASCO Health Policy Leadership Development Program – formerly named the Health Policy Fellowship – is a...
Researchers screened more than 50,000 people for BRCA gene mutations, and found that of the 267 who had variants of the genes, slightly less than a fifth had known of their risk for cancer before the study.
Richard SchilskyYikes! Eighty percent of people with genetic cancer risks are unaware
The Reagan-Udall Foundation for the FDA will honor two longtime U.S. Food and Drug Administration leaders and an independent public-private partnership as the 2018 recipients of the Innovations in Regulatory Science Awards.
NCI Director Dr. Ned Sharpless announces the release of the institute’s Fiscal Year 2020 Annual Plan and Budget Proposal. The plan represents NCI’s best professional judgement on the optimum funding needed to make the most rapid progress against...
Richard SchilskyStill work to be done but also great opportunity! NCI FY 2020 Annual Plan and Budget Proposal Released
A ProPublica analysis found that black people and Native Americans are under-represented in clinical trials of new drugs, even when the treatment is aimed at a type of cancer that disproportionately affects them.
Richard SchilskySame story could be told for older patients, other minority groups. Black patients miss out on promising cancer drugs
The American Society of Clinical Oncology (ASCO) today issued a set of recommendations for overcoming financial barriers to patient participation in cancer clinical trials. ASCO’s policy statement, “Addressing Financial Barriers to Patient...
Richard SchilskyFinancial barriers to clinical trial participation loom large.